Format

Send to

Choose Destination
See comment in PubMed Commons below
Semin Cancer Biol. 2010 Apr;20(2):93-7. doi: 10.1016/j.semcancer.2010.02.001. Epub 2010 Feb 24.

Cancer as a reprogramming-like disease: implications in tumor development and treatment.

Author information

1
Instituto de Biología Molecular y Celular del Cáncer, Centro de Investigación del Cáncer, CSIC/Universidad de Salamanca, Campus M. Unamuno s/n, 37007 Salamanca, Spain.

Abstract

Cancer is a clonal malignant disease originated in a single cell and characterized by the accumulation of partially differentiated cells that are phenotypically reminiscent of normal stages of differentiation. Given the fact that human cancer is diagnosed at later stages and cannot be monitored during its natural evolution, the origin of tumors has been a subject of continuing discussion. Animal models provide a means to determine the identity of the cell-of-origin leading to malignancy and to develop new treatments. Recent findings in mice have shown that cancer stem cells could arise through a reprogramming-like mechanism, suggesting that genetic lesions that initiate the cancer process might be dispensable for tumor progression and maintenance. This review addresses the impact of these results toward a better understanding of carcinogenesis and proposes research avenues for tackling these issues in the future.

PMID:
20188174
DOI:
10.1016/j.semcancer.2010.02.001
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center